CDTI Innovación and ERDF funding support Inmunotek in the development of new therapies for dust mite allergy

by Inmunotek

Reducing treatment duration, improving patient adherence, and changing the course of allergic disease caused by house dust mites are the goals of the new generation of vaccines developed by Inmunotek ...

Read more

CDTI Innovación invests in Ona Therapeutics, together with five co-investors

by Professional Newco

Ona Therapeutics is a pioneer in the development of first-in-class antibody-drug conjugates (ADCs) that leverage the molecular basis of advanced cancer. Through collaboration with academic and clinica...

Read more

Nanoligent closes €12 million funding round to advance the development of its oncology nanodrug

by Nanoligent

Nanoligent is a company whose goal is to develop new anticancer drugs specifically targeting aggressive tumors, using a pioneering technological platform based on protein–drug nanoconjugates. The co...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New breakthrough in developing more pers...

by Universitat de Barcelona

The results show that adenocarcinoma exhibits much more active and fun...

Photos Stream